Acta Metallurgica Sinica

Previous Articles     Next Articles

Acquisition methods of pathological evidence before neoadjuvant chemotherapy for ovarian cancer.

LI XiaoLIN Bei.   

  1. Department of Obstetrics and Gynaecology,Shengjing Hospital Affiliated to China Medical University,Shenyang 110004,China
  • Online:2016-09-02 Published:2016-09-06

卵巢癌新辅助化疗前病理证据获取方法

李潇林蓓   

  1. 作者单位:中国医科大学附属盛京医院妇产科,辽宁 沈阳 110004
  • 通讯作者: 林蓓

Abstract:

Abstract: Neoadjuvant chemotherapy showed an advantage in the treatment of patients with advanced ovarian cancer。It is particularly important to obtain pathological evidence before neoadjuvant chemotherapy. Currently,abdominal fine needle aspiration biopsy,transvaginal fine needle aspiration biopsy,lymph node biopsy,pleural effusion or peritoneal cytology,laparoscopic biopsy and laparotomy biopsy were used in clinical work. The purpose of this article is to describe the methods mentioned above and discuss their advantages and disadvantages.

Key words: ovarian cancer, neoadjuvant chemotherapy, pathology

摘要:

新辅助化疗对于晚期卵巢癌患者的治疗具有明显优势,而化疗前获得足够的病理证据就显得尤为重要。目前,经腹壁细针穿刺活检、经阴道细针穿刺活检、淋巴结穿刺活检、胸腹水细胞学穿刺检查、腹腔镜探查取活检及开腹探查取活检等为临床使用的几种方法,文章就上述方法的选择及其优弊进行阐述。

关键词: 卵巢癌, 新辅助化疗, 病理

CLC Number: